Tacrolimus Drug Exposure Level and Smoking Are Modifiable Risk Factors for Early De Novo Malignancy After Liver Transplantation for Alcohol-Related Liver Disease.

MLA

Vanlerberghe, Benedict T. K., et al. “Tacrolimus Drug Exposure Level and Smoking Are Modifiable Risk Factors for Early De Novo Malignancy After Liver Transplantation for Alcohol-Related Liver Disease.” Transplant International, Mar. 2024, pp. 1–8. EBSCOhost, https://doi.org/10.3389/ti.2024.12055.

APA

Vanlerberghe, B. T. K., van Malenstein, H., Sainz-Barriga, M., Jochmans, I., Cassiman, D., Monbaliu, D., van der Merwe, S., Pirenne, J., Nevens, F., & Verbeek, J. (2024). Tacrolimus Drug Exposure Level and Smoking Are Modifiable Risk Factors for Early De Novo Malignancy After Liver Transplantation for Alcohol-Related Liver Disease. Transplant International, 1–8. https://doi.org/10.3389/ti.2024.12055

Chicago

Vanlerberghe, Benedict T. K., Hannah van Malenstein, Mauricio Sainz-Barriga, Ina Jochmans, David Cassiman, Diethard Monbaliu, Schalk van der Merwe, Jacques Pirenne, Frederik Nevens, and Jef Verbeek. 2024. “Tacrolimus Drug Exposure Level and Smoking Are Modifiable Risk Factors for Early De Novo Malignancy After Liver Transplantation for Alcohol-Related Liver Disease.” Transplant International, March, 1–8. doi:10.3389/ti.2024.12055.